P21cip1 degradation in differentiated keratinocytes is abrogated by costabilization with cyclin E induced by human papillomavirus E7

被引:44
作者
Noya, F [1 ]
Chien, WM [1 ]
Broker, TR [1 ]
Chow, LT [1 ]
机构
[1] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA
关键词
D O I
10.1128/JVI.75.13.6121-6134.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human papillomavirus (HPV) E7 protein promotes S-phase reentry in a fraction of postmitotic, differentiated keratinocytes. Here we report that these cells contain an inherent mechanism that opposes E7-induced DNA replication. In organotypic raft cultures of primary human keratinocytes, neither cyclin E nor p21cip1 is detectable in situ, However, E7-transduced differentiated cells not in S phase accumulate abundant cyclin E and p21cip1. We show that normally p21cip1 protein is rapidly degraded by proteasomes. In the presence of E7 or E6/E7, p21cip1, cyclin E, and cyclin E2 proteins were all up-regulated, The accumulation of p21cip1 protein is a posttranscriptional event, and ectopic cyclin E expression was sufficient to trigger it. In constract, cdk2 and p27kip1 were abundant in normal differentiated cells and were not significantly affected by E7. Cyclin E, cdk2, and p21cip1 or p27kip1 formed complexes, and relatively little kinase activity was found associated with cyclin E or cdk2. In patient papillomas and E7 raft cultures, all p27kip1-positive cells were negative for bromodeoxyuridine (BrdU) incorporation, but only some also contained cyclin E and p21cip1, In contrast, ail cyclin E-positive cells also contained p27kip1. When the expression of p21cip1 was reduced by rottlerin, a PKC delta inhibitor, p27kip1- and BrdU-positive cells remained unchanged. These observations show that high levels of endogenous p27kip1 can prevent E7-induced S-phase reentry. This inhibition then leads to the stabilization of cyclin E and p21cip1, Since efficient initiation of viral DNA replication requires cyclin E and cdk2, its inhibition accounts for heterogeneous viral activities in productively infected lesions.
引用
收藏
页码:6121 / 6134
页数:14
相关论文
共 83 条
[71]  
Voitenleitner C, 1999, MOL CELL BIOL, V19, P646
[72]   THE P21 INHIBITOR OF CYCLIN-DEPENDENT KINASES CONTROLS DNA-REPLICATION BY INTERACTION WITH PCNA [J].
WAGA, S ;
HANNON, GJ ;
BEACH, D ;
STILLMAN, B .
NATURE, 1994, 369 (6481) :574-578
[73]   An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective [J].
Wang, KKW ;
Nath, R ;
Posner, A ;
Raser, KJ ;
BurokerKilgore, M ;
Hajimohammadreza, I ;
Probert, AW ;
Marcoux, FW ;
Ye, QH ;
Takano, E ;
Hatanaka, M ;
Maki, M ;
Caner, H ;
Collins, JL ;
Fergus, A ;
Lee, KS ;
Lunney, EA ;
Hays, SJ ;
Yuen, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) :6687-6692
[74]   Culprits in the degradation of cyclin E apprehended [J].
Winston, JT ;
Chu, C ;
Harper, JW .
GENES & DEVELOPMENT, 1999, 13 (21) :2751-2757
[75]   Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins [J].
Zariwala, M ;
Liu, JD ;
Xiong, Y .
ONCOGENE, 1998, 17 (21) :2787-2798
[76]   Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types:: evidence for an in vivo role in cervical lesions [J].
Zehbe, I ;
Rätsch, A ;
Alunni-Fabbroni, M ;
Burzlaff, A ;
Bakos, E ;
Dürst, M ;
Wilander, E ;
Tommasino, M .
ONCOGENE, 1999, 18 (13) :2201-2211
[77]  
Zeng YX, 1996, ONCOGENE, V12, P1557
[78]   SEQUENTIAL ACTIVATION OF CYCLIN-E AND CYCLIN-A GENE-EXPRESSION BY HUMAN PAPILLOMAVIRUS TYPE-16 E7 THROUGH SEQUENCES NECESSARY FOR TRANSFORMATION [J].
ZERFASS, K ;
SCHULZE, A ;
SPITKOVSKY, D ;
FRIEDMAN, V ;
HENGLEIN, B ;
JANSENDURR, P .
JOURNAL OF VIROLOGY, 1995, 69 (10) :6389-6399
[79]  
ZerfassThome K, 1996, ONCOGENE, V13, P2323
[80]   The cyclin-dependent kinase inhibitor p21(cip1) mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells [J].
Zezula, J ;
Sexl, V ;
Hutter, C ;
Karel, A ;
Schutz, W ;
Freissmuth, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (47) :29967-29974